Encellin Announces Interim Clinical Results Showing First-in-Human Non-Fibrotic Engraftment and Viable Encapsulated Human Islets in Subjects with Type 1 Diabetes
Previous
Previous
Vivere Oncotherapies Announces >$10M Funding to Develop Targeted Therapies for Solid Tumors
Next
Next